#MRNA

Caroline Coram

CarolineCoramUK

PHARMA: When we have an ‘outbreak’ of something there are usually one or two companies that lead and develop supposedly preventative vaccines. This time round we have every Pharma company

Andrew Lee

andrewleedr

One of the fears some members of the public have about vaccines is the erroneous idea that there are too many vaccines being given and that it would overwhelm a

Dr Michelle Ananda-Rajah

rajah_mich

A country like ranked 8th globally for its pandemic response should be backing up its gains with the most efficacious vaccines rather than making do. Tweaking our program is

Ashish K. Jha, MD, MPH

ashishkjha

I've been thinking about the debate of delayed vs. immediate 2nd dose for some timeOver past week, have become convinced that getting all doses out now is betterIts NOT a

Eric Feigl-Ding

DrEricDing

BREAKING—new #COVID19 vaccine efficacy study from Israel concludes that Pfizer/BioNTech's jab is up to 85% effective after the first dose after 15 days to day 28—and even 75% including asymptomatic

Alex Tabarrok

ATabarrok

I have argued for delaying the second dose in order to hit the virus hard and get more people the first dose. Now epidemiologist @michaelmina_lab and @zeynep make the case

Felix Lansing

felix_lansing

I’m happy to share my #PhD work on @biorxivpreprint. We used directed evolution to generate designer recombinases to correct a 140 kb genomic inversion causing Hemophilia A. 1/10https://www.biorxiv.org/content/10.1101/2020.11.02.328013v1T

Liz Szabo

LizSzabo

What's the scoop on coronavirus vaccines? Follow this thread and read our story to get the essentials. 1/https://www.scientificamerican.com/article/fauci-optimistic-about-covid-19-vaccines-though-immunity-unknowns-complicate-development

Dylan Morris

dylanhmorris

Virus antigenic evolution is not the same thing as bacterial antibiotic resistance. Intuitions from one may not apply to the other, for a variety of reasons One of many reasons

Brian Young 🌊🙅🏿‍♂️🙅🏿‍♀️💛Wakanda 4evs

LCARS_TechGuy

Today, I am a part of the phase 3 trial of the Johnson & Johnson COVID19 trial study (http://www.ensemblestudy.com ) which requires only one shot. It's a double blind study so

Viki Male 💙

VikiLovesFACS

I am instinctively uneasy about the proposal to delay/skip the second dose of #COVID19 #vaccine. My worry is that the protection will be incomplete and/or wane. Here is some data

Roshana Mehdian-Staffell

RoshanaMN

Vaccine 1 dose strategy Been doing some digging about Pfizer efficacy after one dose and data behind the decision So in the graph the vaccine injected group line flattens out

C4 News FactCheck

FactCheck

Pfizer have been talking about the tests they carried out on their new #covid19 vaccine. This is the evidence the UK regulator looked at before deciding the mRNA vaccine was

Mrs S

MRSS11224611

Do you understand how this new RNA vaccine works?I didn't think so.Because if you did there's no way in hell you would have it. Here's a nice layman's explanation from

Eric Topol

EricTopol

For evaluating the vaccine trials (and any trials), it's important to look at the number of endpoints and their severity.The J&J trial has the same number of endpoints as @Pfizer/

Buzz Hollander MD

buzzhollandermd

Our first real world data on vaccine effectiveness in the US is here, complements of the Mayo Clinic.Spoiler alert: it is good!It's not a randomized trial, of course;and the cohort

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.